FindTrial
Sign In

Clinical outcomes of SMILE performed with VISUMAX 800 using different parameters

Intraoperative tissue separation and immediate visual quality following SMILE performed with VISUMAX800 using different energy and spot spacing parameters - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/085340
Enrollment
60
Registered
2025-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

Intervention1: SMILE surgery with VISUMAX 800: Tissue separation and immediate visual acuity of patients undergoing SMILE by altering different spot spacing parameters

Sponsors

ZEISS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: myopia or myopic astigmatism between -2 to -10D

Exclusion criteria

Exclusion criteria: patients with keratoconus, dry eye, PMD.

Design outcomes

Primary

MeasureTime frame
UCVA ,CVA MANIFEST FREFRACTION OSI MTFTimepoint: pod1 , pod 15—

Secondary

MeasureTime frame
OSI MTFTimepoint: post op 3 months—

Countries

India

Contacts

Public ContactJanki Bhayani

Nethradhama superspeciality eye hospital

bhayanidrjanki@gmail.com07357759879

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026